Found: 80
Select item for more details and to access through your institution.
A Pragmatic Approach to Introducing Translational Geroscience Into the Clinic: A Paradigm Based on the Incremental Progression of Aging-Related Clinical Research.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2024, v. 79, n. 9, p. 1, doi. 10.1093/gerona/glae062
- By:
- Publication type:
- Article
Bringing Geroscience into the Mainstream: From Education to Clinical Practice, What Will It Take?
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2024, v. 79, n. 9, p. 1, doi. 10.1093/gerona/glae020
- By:
- Publication type:
- Article
Substance P signaling mediates BMP-dependent heterotopic ossification.
- Published in:
- Journal of Cellular Biochemistry, 2011, v. 112, n. 10, p. 2759, doi. 10.1002/jcb.23259
- By:
- Publication type:
- Article
Retinoid Agonists in the Targeting of Heterotopic Ossification.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 11, p. 3245, doi. 10.3390/cells10113245
- By:
- Publication type:
- Article
Correction to: Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Matrix metalloproteinase-9 deficiency confers resilience in fibrodysplasia ossificans progressiva in a man and mice.
- Published in:
- Journal of Bone & Mineral Research, 2024, v. 39, n. 4, p. 382, doi. 10.1093/jbmr/zjae029
- By:
- Publication type:
- Article
Reduction of New Heterotopic Ossification (HO) in the Open-Label, Phase 3 MOVE Trial of Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP).
- Published in:
- Journal of Bone & Mineral Research, 2023, v. 38, n. 3, p. 381, doi. 10.1002/jbmr.4762
- By:
- Publication type:
- Article
Functional Testing of Bone Morphogenetic Protein (BMP) Pathway Variants Identified on Whole‐Exome Sequencing in a Patient with Delayed‐Onset Fibrodysplasia Ossificans Progressiva (FOP) Using ACVR1<sup>R206H</sup>‐Specific Human Cellular and Zebrafish Models
- Published in:
- Journal of Bone & Mineral Research, 2022, v. 37, n. 11, p. 2058, doi. 10.1002/jbmr.4711
- By:
- Publication type:
- Article
Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial.
- Published in:
- Journal of Bone & Mineral Research, 2022, v. 37, n. 10, p. 1891, doi. 10.1002/jbmr.4655
- By:
- Publication type:
- Article
Bone Marrow Adiposity in Models of Radiation‐ and Aging‐Related Bone Loss Is Dependent on Cellular Senescence.
- Published in:
- Journal of Bone & Mineral Research, 2022, v. 37, n. 5, p. 997, doi. 10.1002/jbmr.4537
- By:
- Publication type:
- Article
Plasma‐Soluble Biomarkers for Fibrodysplasia Ossificans Progressiva (FOP) Reflect Acute and Chronic Inflammatory States.
- Published in:
- Journal of Bone & Mineral Research, 2022, v. 37, n. 3, p. 475, doi. 10.1002/jbmr.4492
- By:
- Publication type:
- Article
Clearance of Senescent Cells From Injured Muscle Abrogates Heterotopic Ossification in Mouse Models of Fibrodysplasia Ossificans Progressiva.
- Published in:
- Journal of Bone & Mineral Research, 2022, v. 37, n. 1, p. 95, doi. 10.1002/jbmr.4458
- By:
- Publication type:
- Article
Bone From Blood: Characteristics and Clinical Implications of Circulating Osteogenic Progenitor (COP) Cells.
- Published in:
- Journal of Bone & Mineral Research, 2021, v. 36, n. 1, p. 12, doi. 10.1002/jbmr.4204
- By:
- Publication type:
- Article
Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy‐Related Bone Loss.
- Published in:
- Journal of Bone & Mineral Research, 2020, v. 35, n. 6, p. 1119, doi. 10.1002/jbmr.3978
- By:
- Publication type:
- Article
Identification of Senescent Cells in the Bone Microenvironment.
- Published in:
- 2016
- By:
- Publication type:
- Other
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.
- Published in:
- Journal of Bone & Mineral Research, 2016, v. 31, n. 10, p. 1910, doi. 10.1002/jbmr.2918
- By:
- Publication type:
- Article
Cellular Hypoxia Promotes Heterotopic Ossification by Amplifying BMP Signaling.
- Published in:
- 2016
- By:
- Publication type:
- Other
The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment.
- Published in:
- Journal of Bone & Mineral Research, 2016, v. 31, n. 3, p. 650, doi. 10.1002/jbmr.2728
- By:
- Publication type:
- Article
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.
- Published in:
- Journal of Bone & Mineral Research, 2016, v. 31, n. 1, p. 16, doi. 10.1002/jbmr.2708
- By:
- Publication type:
- Article
Heterozygous inactivation of Gnas in adipose-derived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification.
- Published in:
- Journal of Bone & Mineral Research, 2011, v. 26, n. 11, p. 2647, doi. 10.1002/jbmr.481
- By:
- Publication type:
- Article
Circulating osteogenic cells: Implications for injury, repair, and regeneration.
- Published in:
- Journal of Bone & Mineral Research, 2011, v. 26, n. 8, p. 1685, doi. 10.1002/jbmr.370
- By:
- Publication type:
- Article
Viewing FOP Through Rosi-Colored Glasses.
- Published in:
- 2010
- By:
- Publication type:
- Opinion
Serum vitamin C levels modulate the lifespan and endoplasmic reticulum stress response pathways in mice synthesizing a nonfunctional mutant WRN protein.
- Published in:
- FASEB Journal, 2018, v. 32, n. 7, p. 3623, doi. 10.1096/fj.201701176R
- By:
- Publication type:
- Article
Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.
- Published in:
- FASEB Journal, 2018, v. 32, p. 52, doi. 10.1096/fj.201700375R
- By:
- Publication type:
- Article
Proteasome inhibitor bortezomib is a novel therapeutic agent for focal radiation-induced osteoporosis.
- Published in:
- FASEB Journal, 2018, v. 32, n. 1, p. 52, doi. 10.1096/fj.201700375R
- By:
- Publication type:
- Article
Fibrodysplasia ossificans progressiva: a blueprint for metamorphosis.
- Published in:
- Annals of the New York Academy of Sciences, 2011, v. 1237, n. 1, p. 5, doi. 10.1111/j.1749-6632.2011.06195.x
- By:
- Publication type:
- Article
Morphogen Receptor Genes and Metamorphogenes.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1116, p. 113, doi. 10.1196/annals.1402.039
- By:
- Publication type:
- Article
Rural–urban health disparities for mood disorders and obesity in a midwestern community.
- Published in:
- Journal of Clinical & Translational Science, 2020, v. 4, n. 5, p. 408, doi. 10.1017/cts.2020.27
- By:
- Publication type:
- Article
Clinical Utility Gene Card for: Fibrodysplasia ossificans progressiva.
- Published in:
- European Journal of Human Genetics, 2015, v. 23, n. 10, p. -1, doi. 10.1038/ejhg.2014.274
- By:
- Publication type:
- Article
Whole-body Computed Tomography Versus Dual Energy X‑ray Absorptiometry for Assessing Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Paths of Emergency Department Care: Development of a Decision Aid to Facilitate Shared Decision Making in Goals of Care Discussions in the Acute Setting.
- Published in:
- MDM Policy & Practice, 2021, v. 6, n. 2, p. 1, doi. 10.1177/23814683211058082
- By:
- Publication type:
- Article
Fibrodysplasia Ossificans Progressiva (FOP): A Segmental Progeroid Syndrome.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. 1, doi. 10.3389/fendo.2019.00908
- By:
- Publication type:
- Article
"I Can't Take off My Shirt or Do My Own Hair"—A Qualitative Investigation of the Symptoms and Impact Experience of Children and Adolescents with Fibrodysplasia Ossificans Progressiva (FOP).
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2796, doi. 10.1007/s12325-022-02096-3
- By:
- Publication type:
- Article
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.
- Published in:
- Frontiers in Endocrinology, 2021, v. 12, p. 1, doi. 10.3389/fendo.2021.732728
- By:
- Publication type:
- Article
Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.
- Published in:
- Current Osteoporosis Reports, 2019, v. 17, n. 2, p. 70, doi. 10.1007/s11914-019-00504-2
- By:
- Publication type:
- Article
The Immunological Contribution to Heterotopic Ossification Disorders.
- Published in:
- Current Osteoporosis Reports, 2015, v. 13, n. 2, p. 116, doi. 10.1007/s11914-015-0258-z
- By:
- Publication type:
- Article
REcognizing DElirium in geriatric Emergency Medicine: The REDEEM risk stratification score.
- Published in:
- Academic Emergency Medicine, 2022, v. 29, n. 4, p. 476, doi. 10.1111/acem.14423
- By:
- Publication type:
- Article
Brief Report: Long-Term Functional Engraftment of Mesenchymal Progenitor Cells in a Mouse Model of Accelerated Aging.
- Published in:
- Stem Cells, 2013, v. 31, n. 3, p. 607, doi. 10.1002/stem.1294
- By:
- Publication type:
- Article
Paternally Inherited Gsα Mutation Impairs Adipogenesis and Potentiates a Lean Phenotype In Vivo.
- Published in:
- Stem Cells, 2012, v. 30, n. 7, p. 1477, doi. 10.1002/stem.1109
- By:
- Publication type:
- Article
Circulating Osteogenic Precursor Cells in Heterotopic Bone Formation.
- Published in:
- Stem Cells, 2009, v. 27, n. 9, p. 2209, doi. 10.1002/stem.150
- By:
- Publication type:
- Article
Do the telomere ends justify the physical means?
- Published in:
- 2021
- By:
- Publication type:
- Establishment Review
Fisetin for COVID‐19 in skilled nursing facilities: Senolytic trials in the COVID era.
- Published in:
- Journal of the American Geriatrics Society, 2021, v. 69, n. 11, p. 3023, doi. 10.1111/jgs.17416
- By:
- Publication type:
- Article
Creating the Next Generation of Translational Geroscientists.
- Published in:
- Journal of the American Geriatrics Society, 2019, v. 67, n. 9, p. 1934, doi. 10.1111/jgs.16055
- By:
- Publication type:
- Article
Accelerated Aging in Cyclophilin B–Deficient Mice Downstream of p21‐Cip1/Waf1.
- Published in:
- JBMR Plus, 2022, v. 6, n. 10, p. 1, doi. 10.1002/jbm4.10674
- By:
- Publication type:
- Article
Accelerated Aging in Cyclophilin B–Deficient Mice Downstream of p21‐Cip1/Waf1.
- Published in:
- JBMR Plus, 2022, v. 6, n. 10, p. 1, doi. 10.1002/jbm4.10674
- By:
- Publication type:
- Article
Pharmacologic Interventions for Fracture Risk Reduction in the Oldest Old: What Is the Evidence?
- Published in:
- JBMR Plus, 2021, v. 5, n. 10, p. 1, doi. 10.1002/jbm4.10538
- By:
- Publication type:
- Article
Bone Aging, Cellular Senescence, and Osteoporosis.
- Published in:
- JBMR Plus, 2021, v. 5, n. 4, p. 1, doi. 10.1002/jbm4.10488
- By:
- Publication type:
- Article
Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways.
- Published in:
- Scientific Reports, 2017, p. 45140, doi. 10.1038/srep45140
- By:
- Publication type:
- Article
Cell Senescence in Heterotopic Ossification.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 4, p. 485, doi. 10.3390/biom14040485
- By:
- Publication type:
- Article